neoplasm
N |
• not prone to spontaneous tumors but do show a shift in tumor spectrum
|
|
• no incidence of T-cell lymphoma compared to 3.7% in wild-type mice
|
|
• slightly increased,16.7% incidence compared to 11.8% in wild-type mice
|
liver/biliary system
|
• steatohepatitis in 50% of mice compared to 6% in wild-type mice
|
|
• steatohepatitis in 50% of mice compared to 6% in wild-type mice
|
endocrine/exocrine glands
|
• splenic/thymic hyperplasia in 96% of mice compared to 3.9% of wild-type mice
|
hematopoietic system
|
• splenic/thymic hyperplasia in 96% of mice compared to 3.9% of wild-type mice
|
|
• splenic/thymic hyperplasia in 96% of mice compared to 3.9% of wild-type mice
|
growth/size/body
|
• splenic/thymic hyperplasia in 96% of mice compared to 3.9% of wild-type mice
|
immune system
|
• splenic/thymic hyperplasia in 96% of mice compared to 3.9% of wild-type mice
|
|
• splenic/thymic hyperplasia in 96% of mice compared to 3.9% of wild-type mice
|
|
• steatohepatitis in 50% of mice compared to 6% in wild-type mice
|
mortality/aging
|
• median survival time (89.3 weeks) is decreased compared to wild-type controls (117 weeks)
|